Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

The Metabolic Dysfunction–Associated Steatotic Liver Disease–CKD Axis: Intersecting Pathways and Opportunities for Early Intervention

Kidney International Reports(2025)10.1016/j.ekir.2025.103757Source: DataRank Database

The Metabolic Dysfunction–Associated Steatotic Liver Disease–CKD Axis: Intersecting Pathways and Opportunities for Early Intervention is a research paper published in Kidney International Reports (2025). On theSindex it has a DataRank of 0.

N/A

0DataRank · unranked

Scored on demand from live citation data

Open Access0 citations

Download PDF

Cite:

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (5 grants)Impact (FWCI 1.34)OA: goldTopics (17)IDs (PubMed, PMC, OpenAlex)SDGs (1)

FAIR Checklist

Context only (not used in score)

Findable (1/2)

Has DOI

Accessible (1/2)

Open Access

Interoperable (0/2)

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

Authors (4)

Prathab Balaji Saravanan ORCID,Gaurav Gupta ORCID,Arun Sanyal,Sriram Sriperumbuduri ORCID

Live enrichment

PubMed:41726005 PMC:PMC12924124 OpenAlex:https://openalex.org/W7117658254

National Institute of Allergy and Infectious Diseases

National Institute of Diabetes and Digestive and Kidney Diseases

CareDx

National Institutes of Health

Alnylam Pharmaceuticals

FWCI

1.34

Citation Percentile

0.8%

Citation Trend

2026

goldLicense: cc-by-nc-nd

journalhttps://www.kireports.org/article/S2468-0249(25)00775-2/pdf

publisherhttps://www.kireports.org/article/S2468-0249(25)00775-2/pdf

publisherhttps://api.elsevier.com/content/article/PII:S2468024925007752?httpAccept=text/xml

publisherhttps://api.elsevier.com/content/article/PII:S2468024925007752?httpAccept=text/plain

journalhttps://doi.org/10.1016/j.ekir.2025.103757

Fields of Study

Liver Disease Diagnosis and TreatmentChronic Kidney Disease and DiabetesDiabetes, Cardiovascular Risks, and Lipoproteins

Keywords

Kidney diseaseDiseaseSteatohepatitisFatty liverDiabetes mellitusLiver diseaseIntervention (counseling)Metabolic syndromeKidneyGlp-1 AgonistsCkdRaasiSglt2iMasld

Sustainable Development Goals

SDG 0: Good health and well-being